178 related articles for article (PubMed ID: 28695379)
1. Expression of prostaglandin E
Dinç E; Dursun Ö; Yılmaz B; Vatansever M; Sarı AA; Yıldırım Ö; Adıgüzel U
Int Ophthalmol; 2018 Aug; 38(4):1703-1708. PubMed ID: 28695379
[TBL] [Abstract][Full Text] [Related]
2. Distribution of vimentin-expressing cells in pterygium: an immunocytochemical study of impression cytology specimens.
Chen YT; Tseng SH; Tsai YY; Huang FC; Tseng SY
Cornea; 2009 Jun; 28(5):547-52. PubMed ID: 19421041
[TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of cannabinoid receptor type 1 and CB2 cannabinoid receptors, and transient receptor potential vanilloid channels in pterygium.
Assimakopoulou M; Pagoulatos D; Nterma P; Pharmakakis N
Mol Med Rep; 2017 Oct; 16(4):5285-5293. PubMed ID: 28849159
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical profile of VEGF, TGF-β and PGE₂ in human pterygium and normal conjunctiva: experimental study and review of the literature.
Bianchi E; Scarinci F; Grande C; Plateroti R; Plateroti P; Plateroti AM; Fumagalli L; Capozzi P; Feher J; Artico M
Int J Immunopathol Pharmacol; 2012; 25(3):607-15. PubMed ID: 23058011
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E receptor 4 expression in human conjunctival epithelium and its downregulation in devastating ocular surface inflammatory disorders.
Ueta M; Sotozono C; Yokoi N; Inatomi T; Kinoshita S
Arch Ophthalmol; 2010 Oct; 128(10):1369-71. PubMed ID: 20938012
[No Abstract] [Full Text] [Related]
6. Overexpression of fractalkine and its histopathological characteristics in primary pterygium.
Turan M; Turan G
Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2743-2750. PubMed ID: 31637486
[TBL] [Abstract][Full Text] [Related]
7. Assessment of miR-182, miR-183, miR-184, and miR-221 Expressions in Primary Pterygium and Comparison With the Normal Conjunctiva.
İçme G; Yilmaz A; Dinç E; Görür A; Fidanci ŞB; Tamer L
Eye Contact Lens; 2019 May; 45(3):208-211. PubMed ID: 30688676
[TBL] [Abstract][Full Text] [Related]
8. Claudin-1 expressions decrease in pterygium with respect to normal conjunctiva.
Dogan AS; Onder E; Arikok AT; Bicer T; Gurdal C
Cutan Ocul Toxicol; 2016 Dec; 35(4):315-8. PubMed ID: 26820697
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of c-Myc in pterygium and cultured pterygial cells.
Cui D; Pan Z; Zhang S; Zheng J; Huang Q; Wu K
Clin Exp Ophthalmol; 2011 Nov; 39(8):784-92. PubMed ID: 22050566
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression in primary and recurrent pterygium.
Adiguzel U; Karabacak T; Sari A; Oz O; Cinel L
Eur J Ophthalmol; 2007; 17(6):879-84. PubMed ID: 18050111
[TBL] [Abstract][Full Text] [Related]
11. YKL-40 expression in pterygium: a potential role in the pathogenesis.
Kurt A; Kılıç R; Tad M; Polat OA
Int Ophthalmol; 2019 Jul; 39(7):1445-1450. PubMed ID: 29922975
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2, p53, and Ki-67 expression in pterygium and normal conjunctiva and their relationship with pterygium recurrence.
Turan M; Turan G
Eur J Ophthalmol; 2020 Nov; 30(6):1232-1237. PubMed ID: 32703006
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 and NLRP6 expression in pterygium and normal conjunctiva and their relationship with pterygium formation and recurrence.
Guo Z; Wang Y; Wang L; Li Q; Yuan X; Hua X
Eur J Ophthalmol; 2022 Sep; 32(5):3058-3063. PubMed ID: 35068231
[TBL] [Abstract][Full Text] [Related]
14. Regulation of vascular endothelial growth factor-C by tumor necrosis factor-α in the conjunctiva and pterygium.
Dong Y; Kase S; Dong Z; Fukuhara J; Tagawa Y; Ishizuka ET; Murata M; Shinmei Y; Ohguchi T; Kanda A; Noda K; Ishida S
Int J Mol Med; 2016 Aug; 38(2):545-50. PubMed ID: 27314284
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles of prostaglandin E2 receptor subtypes in aspirin tolerant adult Chinese with chronic rhinosinusitis.
Xie L; Liu AG; Cui YH; Zhang YP; Liao B; Li NN; Wang XS
Am J Rhinol Allergy; 2015; 29(5):322-8. PubMed ID: 26358341
[TBL] [Abstract][Full Text] [Related]
16. Induction of endothelial RAGE expression in pterygium.
Al-Swailem S; Xu Z; Wu L; Hartsock MJ; Yiu SC; Duh EJ
Mol Vis; 2014; 20():1740-8. PubMed ID: 25593504
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues--a comparative immunohistochemical study.
Biswas S; Bhattacherjee P; Paterson CA
Prostaglandins Leukot Essent Fatty Acids; 2004 Nov; 71(5):277-88. PubMed ID: 15380814
[TBL] [Abstract][Full Text] [Related]
18. P63 expression in conjunctival proliferative diseases: pterygium and laryngo-onycho-cutaneous (LOC) syndrome.
Atkinson SD; Moore JE; Shah S; Sharma A; Best RM; Leccisotti A; Alarbi M; Rimmer D; Gardiner T; Moore TC
Curr Eye Res; 2008 Jul; 33(7):551-8. PubMed ID: 18600487
[TBL] [Abstract][Full Text] [Related]
19. Increased Expression of Aquaporin-1 and Aquaporin-3 in Pterygium.
Ortak H; Cayli S; Ocakli S; Demir S
Cornea; 2013 Oct; 32(10):1375-9. PubMed ID: 23974882
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of vascular endothelial growth factor (VEGF) and p53 expression in pterygium from Tunisian patients.
Khalfaoui T; Mkannez G; Colin D; Imen A; Zbiba W; Errais K; Anane R; Beltaief O; Zhioua R; Ben Hamida J; Lizard G; Ouertani-Meddeb A
Pathol Biol (Paris); 2011 Jun; 59(3):137-41. PubMed ID: 19481369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
